09/2009 - Državni zavod za intelektualno vlasništvo

HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 9, 3373 – 3601 3457
(51) MKP
C07D 401/12 (2006.01) (97) EP 2086963 *
C07D 401/14 (2006.01)
C07D 417/14 (2006.01)
C07K 5/00 (2006.01)
A61K 31/4709 (2006.01)
A61P 31/14 (2006.01)
(86) PCT/US2007084012 08.11.2007.
(96) EP 07864081.0 08.11.2007.
(87) WO2008060927, 22.05.2008. 200821
(97) EP 2086963, 12.08.2009. 200933, En
(31) 865034 P (32) 09.11.2006. (33) US
934840 05.11.2007. US
(54) HEPATITIS C VIRUS INHIBITORS
(71) Bristol-Myers Squibb Company, Route 206 and Province Line
Road, Princeton, NJ 08543-4000, US
(72) SIN, Ny, Bristol-Myers Squibb Co. 5 Research Parkway,
Wallingford, Connecticut 06492, US
VENABLES, Brian Lee, Bristol-Myers Squibb Co. 5 Research
Parkway, Wallingford, Connecticut 06492, US
SUN, Li-Qiang, Bristol-Myers Squibb Co. 5 Research Parkway,
Wallingford, Connecticut 06492, US
SIT, Sing-Yuen, Bristol-Myers Squibb Co. 5 Research Parkway,
Wallingford, Connecticut 06492, US
CHEN, Yan, Bristol-Myers Squibb Co. 5 Research Parkway,
Wallingford, Connecticut 06492, US
SCOLA, Paul Michael, Bristol-Myers Squibb Co. 5 Research
Parkway, Wallingford, Connecticut 06492, US
(51) MKP
C07D 401/12 (2006.01) (97) EP 2094683 *
C07D 401/14 (2006.01)
C07D 211/14 (2006.01)
C07D 211/24 (2006.01)
C07D 211/16 (2006.01)
C07D 405/14 (2006.01)
C07D 413/04 (2006.01)
A61K 31/4545 (2006.01)
A61K 31/496 (2006.01)
A61P 3/00 (2006.01)
C07D 413/14 (2006.01)
(86) PCT/US2007086434 05.12.2007.
(96) EP 07868992.4 05.12.2007.
(87) WO2008070692, 12.06.2008. 200824
(97) EP 2094683, 02.09.2009. 200936, En
(31) 868789 P (32) 06.12.2006. (33) US
(54) BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS
(71) SmithKline Beecham Corporation, One Franklin Plaza P.O. Box
7929, Philadelphia, PA 19101, US
(72) FANG, Jing, GlaxoSmithKline Corporate Intellectual Property
Department Five Moore Drive PO Box 13398, Research Triangle
Park, NC 27709, US
TANG, Jun, GlaxoSmithKline Corporate Intellectual Property
Department Five Moore Drive PO Box 13398, Research Triangle
Park, NC 27709, US
CARPENTER, Andrew J., GlaxoSmithKline Corporate Intellectual
Property Department Five Moore Drive PO Box 13398, Research
Triangle Park, NC 27709, US
PECKHAM, Gregory, GlaxoSmithKline Corporate Intellectual
Property Department Five Moore Drive PO Box 13398, Research
Triangle Park, NC 27709, US
CONLEE, Christopher R., GlaxoSmithKline Corporate Intellectual
Property Department Five Moore Drive PO Box 13398, Research
Triangle Park, NC 27709, US
DU, Kien S., GlaxoSmithKline Corporate Intellectual Property
Department Five Moore Drive PO Box 13398, Research Triangle
Park, NC 27709, US
KATAMREDDY, Subba Reddy, GlaxoSmithKline Corporate
Intellectual Property Department Five Moore Drive PO Box 13398,
Research Triangle Park, NC 27709, US
(51) MKP
C07D 401/12 (2006.01) (97) EP 2091941 *
C07D 403/06 (2006.01)
C07D 405/12 (2006.01)
C07D 413/06 (2006.01)
C07D 239/557 (2006.01)
C07D 239/545 (2006.01)
A61K 31/513 (2006.01)
A61P 35/00 (2006.01)
(86) PCT/US2007082138 22.10.2007.
(96) EP 07874225.1 22.10.2007.
(87) WO2008140553, 20.11.2008. 200847
(97) EP 2091941, 26.08.2009. 200935, En
(31) 862569 P (32) 23.10.2006. (33) US
(54) MAPK/ERK KINASE INHIBITORS
(71) Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-
chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
(72) DONG, Qing, 12935 Flintwood Way, San Diego, CA 92130, US
FEHER, Victoria, 12658 Carmel Country Road, 89, San Diego, CA
92130, US
KALDOR, Stephen W., 4887 Del Mar Mesa Road, Del Mar, CA
92130, US
TOMITA, Naoki, c/o TAKEDA PHARMACEUTICAL COMPANY
LIMITED 17-85 Jusohonmachi 2-chome Yodogawa-ku, Osaka 532-
8686, JP
(51) MKP
C07D 401/14 (2006.01) (97) EP 2086964 *
C07D 403/12 (2006.01)
C07D 403/14 (2006.01)
C07D 411/14 (2006.01)
C07D 413/14 (2006.01)
C07D 417/14 (2006.01)
C07D 419/14 (2006.01)
A61K 31/497 (2006.01)
A61K 31/4155 (2006.01)
A61K 31/554 (2006.01)
A61K 31/444 (2006.01)
A61K 31/553 (2006.01)
A61K 31/5355 (2006.01)
A61P 3/10 (2006.01)
(86) PCT/GB2007004018 22.10.2007.
(96) EP 07824267.4 22.10.2007.
(87) WO2008050101, 02.05.2008. 200818
(97) EP 2086964, 12.08.2009. 200933, En
(31) 862493 P (32) 23.10.2006. (33) US
891993 P 28.02.2007. US
(54) BENZOYL AMINO HETEROCYCLYL COMPOUNDS USEFUL IN
THE TREATMENT OF A DISEASE MEDIATED THROUGH GLK
(71) Astra Zeneca AB, , 151 85 Södertälje, SE
(72) CAMPBELL, Leonie, AstraZeneca R & D Alderley Alderley Park,
Macclesfield Cheshire SK10 4TG, GB
PIKE, Kurt Gordon, AstraZeneca R & D Alderley Alderley Park,
Macclesfield Cheshire SK10 4TG, GB
SULEMAN, Abid, AstraZeneca R & D Alderley Alderley Park,
Macclesfield Cheshire SK10 4TG, GB
WARING, Michael James, AstraZeneca R & D Alderley Alderley
Park, Macclesfield Cheshire SK10 4TG, GB
(51) MKP
C07D 401/14 (2006.01) (97) EP 2091946 *
A61K 31/4545 (2006.01)
A61P 31/12 (2006.01)
(86) PCT/GB2007004706 10.12.2007.
(96) EP 07848454.0 10.12.2007.
(87) WO2008071927, 19.06.2008. 200825
(97) EP 2091946, 26.08.2009. 200935, En
(31) 869436 P (32) 11.12.2006. (33) US
(54) PIPERIDINE DERIVATIVE USED FOR TREATING CHEMOKINE
RECEPTOR 5 MEDIATED DISEASES
(71) AstraZeneca AB, , 151 85 Södertälje, SE
(72) FAULL, Alan Wellington, AstraZeneca Intellectual property Alderley
Park, Macclesfield Cheshire SK10 4TG, GB
SWALLOW, Steven, AstraZeneca R & D Alderley Alderley Park,
Macclesfield Cheshire SK10 4TG, GB
(51) MKP
C07D 401/14 (2006.01) (97) EP 2089382 *
C07D 413/14 (2006.01)
C07D 471/04 (2006.01)
C07D 487/04 (2006.01)
C07D 491/048 (2006.01)
C07D 491/052 (2006.01)
C07D 495/04 (2006.01)
A61K 31/551 (2006.01)
A61P 3/04 (2006.01)
A61P 25/20 (2006.01)
C07D 403/14 (2006.01)
ISSN 1331-2030